vitreoretinal configuration of Stage 4 retinopathy of prematurity in photocoagulated and treatment-naive eyes undergoing vitrectomy
Dear Sir, We read with great interest the article, "Variation in the vitreoretinal configuration of Stage 4 retinopathy of prematurity (ROP) in photocoagulated and treatment-naive eyes undergoing vitrectomy" by Gadkari and Deshpande. [1] We congratulate the authors for their work. In a well-illustrated series, they demonstrate that laser-treated eyes with Stage 4 ROP presented with predominant central traction which could be managed by lens-sparing vitrectomy. On the contrary, treatment-naive eyes had more of peripheral traction requiring lensectomy at times and more chances of iatrogenic breaks. We wish to add certain pertinent points to the discussion.
The authors postulate that the junction between the ischemic and nonischemic retina is shifted posteriorly in photocoagulated eyes, resulting in more of central or lenticular traction rather than peripheral traction. However, we must also consider the type and zone of ROP as an important determinant of traction. For instance, retinal detachments in eyes with zone 1 aggressive posterior ROP (APROP) often evolve from flat preretinal vitreous organization which begins nasally, close to the optic disc. [2, 3] In later stages, the traction spreads circumferentially along posterior arcade resulting in Stage 4b or 5 detachment. [2, 3] In such eyes, traction is more likely to be posterior/central as opposed to peripheral traction arising out of a ridge in classical staged zone 2 ROP. If we closely observe representative Figs. 1-5 of the original article, [1] traction is predominant nasally and close to the optic disc. These are most likely eyes with zone 1 APROP which progressed despite laser treatment. Preretinal hemorrhages before or after laser treatments are another factor which cause significant vitreous organization, fibrovascular proliferation, and detachments in eyes with both APROP as well as threshold ROP. [3, 4] In the present study, [1] we observe hemorrhages underlying/close to the area of fibrovascular proliferation [Figs. 1, 4 and 5].
The authors discuss a scenario where the ischemic retina is central and more laser is not possible, as laser has already been done up to the posterior arcade. We must add that such a scenario with extensive capillary bed loss and ischemia in the vascularized posterior retina is described in zone 1 APROP. [5] Such a disease with posterior ischemic retina is less amenable to laser treatment. Often, these eyes develop extensive posterior circumferential traction despite early and confluent laser treatment. [2, 3] Although the authors have not specifically alluded to these eyes as APROP, they rightly point out that additional anti-vascular endothelial growth factor treatment may have a role in such eyes.
The authors themselves conclude that treatment-naive eyes were more likely a milder form of ROP which progressed due to a lack of treatment. These are likely to be eyes with pre-equatorial zone 2 classical staged ROP which progressed and developed peripheral traction in the absence of treatment. These eyes are less likely to develop central traction as posterior vasculature is more mature and well perfused. We believe that the authors should provide information about the baseline disease features (i.e. zone of ROP [zone 1 vs. zone 2], type of ROP [APROP vs. Staged ROP], and preretinal hemorrhages) for the laser treated group. This is important as retinal detachment evolves
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Response to: Variation in the vitreoretinal configuration of Stage 4 retinopathy of prematurity in photocoagulated and treatment naive eyes undergoing vitrectomy
Dear Sir, We thank Drs. Sanghi and Dr. Gupta for their interest in our article. Their comments add important insights into the development of the disease process. Our study looked at the patients when they came for vitreoretinal surgery. Only five out of 16 had been lasered at our hospital. Eleven patients were referred by colleagues outside of our system. Unfortunately, more information about their status at presentation was not available at the time of this study. At present, a more robust system of sharing treatment and diagnosis timeline for such referred patients has been established. Out of the six from our center, three had aggressive posterior retinopathy of prematurity (APROP) and one had zone 1 disease. The argument of the Dr. Sanghi and his careful assessment of the pictures does make a case for APROP being an important determinant in progress in disease despite retinal laser in the absence of laser these patients would have rapidly deteriorated to stage 5 disease. Previous studies have also shown that APROP in heavier (≥1500 g birth weight) premature infants occurs mostly in posterior zone 2 with flat neovascularization and atypical features such as large vascular loops. [1] Notably, a lot of babies in our country presenting with ROP needing surgery are larger. [2] Hence, the location of proliferation should probably have naturally been less central than that observed in our study. Therefore, we feel convinced about the location of the neovascularization/ridge as described in our article. Notably, this always seems to take place at the junction of lasered and nonlasered area and interestingly not further proximal as suggested by Dr. Sanghi. So convincing was the location of the proliferation just posterior to the margin of the nonischemic lasered retina that we had considered, giving it the toponym of "Pune Paradox."
We, however, concede that multiple factors rightly mentioned in the communication could jointly be responsible for central traction. [3] The very nature of the disease and the referral pattern makes it difficult to have large cohorts. All patients at our center underwent RetCam imaging, but these were not available for those referred from elsewhere.
The studied comments in the letter to editor can be starting point for a new study with a national registry of ROP surgery as very few centers offering it at present. The authors acknowledge that all the ROP publications of the PGI differently in zone 1 APROP versus zone 2 classical staged ROP eyes. This will further explain some of the observed differences in morphology of Stage 4 ROP in laser-treated versus treatment-naive eyes.
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